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Abstract
Background: The main objective of this study was to describe the patients who were hospitalised at Oslo
University Hospital Aker during the first wave of pandemic Influenza A (H1N1) in Norway.
Methods: Clinical data on all patients hospitalised with influenza-like illness from July to the end of November
2009 were collected prospectively. Patients with confirmed H1N1 Influenza A were compared to patients with
negative H1N1 tests.
Results: 182 patients were hospitalised with suspected H1N1 Influenza A and 64 (35%) tested positive. Seventeen
patients with positive tests (27%) were admitted to an intensive care unit and four patients died (6%). The H1N1
positive patients were younger, consisted of a higher proportion of non-ethnic Norwegians, had a higher heart
rate on admission, and fewer had pre-existing hypertension, compared to the H1N1 negative patients. However,
hypertension was the only medical condition that was significantly associated with a more serious outcome
defined as ICU admission or death, with a univariate odds ratio of the composite endpoint in H1N1 positive and
negative patients of 6.1 (95% CI 1.3-29.3) and 3.2 (95% CI 1.2-8.7), respectively. Chest radiography revealed
pneumonia in 24/59 H1N1 positive patients. 63 of 64 H1N1 positive patients received oseltamivir.
Conclusions: The extra burden of hospitalisations was relatively small and we managed to admit all the patients
with suspected H1N1 influenza without opening new pandemic isolation wards. The morbidity and mortality were
similar to reports from comparable countries. Established hypertension was associated with more severe morbidity
and patients with hypertension should be considered candidates for vaccination programs in future pandemics.
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Background
After the first cases of the 2009 H1N1 Influenza A were
confirmed during week 30 in 2009, The Norwegian
Ministry of Health asked the Norwegian hospitals and
primary care facilities to activate their plans to cope
with an expected massive wave of Influenza A patients
[1-6]. On June 11, 2009, the World Health Organization
r a i s e dt h ep a n d e m i ca l e r tl e v e lt o6[ 7 , 8 ] .E a r l yo b s e r v a -
tions indicated that up to 95% of infected patients were
under the age of 50 years [9].
Concerns were raised that our health care facilities
were not equipped or prepared to admit all the expected
patients. The need for isolates, ventilators, antivirals and
antibiotics were evaluated, and we feared that lack of
equipment and personnel would cause extra strain on
health care institutions. We also feared that secondary
cases among the personnel would further increase the
workload and compromise care.
The aim of the study was to describe underlying medi-
cal conditions, clinical features, and outcome of the first
2009 H1N1 Influenza A patients at Oslo University
Hospital Aker (OUHA) and to compare these patients
with the patients admitted with suspected 2009 H1N1
Influenza A, but who tested negative for Influenza A.
* Correspondence: b.j.brandsater@medisin.uio.no
1Oslo University Hospital Aker, Department of Infectious Diseases,
Trondheimsveien 235, 0514 Oslo, Norway
Full list of author information is available at the end of the article
Brandsaeter et al. BMC Infectious Diseases 2011, 11:75
http://www.biomedcentral.com/1471-2334/11/75
© 2011 Brandsaeter et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.We also investigated secondary cases and the extra
workload the pandemic put on our hospital facilities
and employees.
Methods
Oslo University Hospital Aker (OUHA)
OUHA serves an area of 180 000 inhabitants. 73 000 of
these live in two different districts of Oslo with approxi-
mately 40% non-ethnic Norwegians. The rest live in
sparsely populated communities, suburbs and rural areas
outside Oslo with about 2-3% non-ethnic Norwegians.
At the time of the pandemic the Department of Medi-
cine had 129 beds. The Department of Infectious Dis-
eases shared 16 beds divided equally with the
Department of Gastroenterology. The Intensive Care
Unit (ICU) consisted of two parts: six general intensive
care beds without the possibility of ventilator but with
equipment for continuous positive airway pressure
(CPAP) and bilevel positive airway pressure (BiPAP)
treatment. The other part of the ICU had six beds with
the possibility for ventilator treatment. There were no
paediatric, gynaecologic or obstetric departments at the
hospital.
Isolation facilities and hygienic precautions
As a preparation for the pandemic all 16 beds were
made available for the Department of Infectious Dis-
eases if needed. There were six single rooms and five
double rooms. The hospital had no negative air-pressure
isolates and few patient rooms with antechamber and
separate bathrooms. In June 2009, all staff in the
involved departments completed an e-learning program
about hygienic rules for handling influenza patients. At
the end of October 2009 all employees at the Emer-
gency, Intensive Care and Infectious Disease Depart-
ments were offered vaccination against Influenza A. In
addition to disposable gowns and gloves, the hospital
staff used surgical masks for protection. If vaporizing
procedures were performed the staff used health care
respirator masks. All suspected influenza patients
admitted to the hospital were initially isolated in single
rooms in the Emergency Department. The patients were
quickly evaluated by nurse and physician and then
moved to either the Intensive Care Unit or to the
Department of Infectious diseases. There were no strict
criteria for ICU admission, but in general patients pre-
senting with several positive SIRS criteria such as heart
rate >100, respiratory rate >25, and fever > 38°C and
hypoxia, were referred to the ICU.
Study Design
From 15 July to 30 November 2009, all hospitalised
patients above 18 years of age with suspected H1N1
Influenza A were enrolled in the study. The responsible
physician registered clinical signs and symptoms, under-
lying medical conditions, bacterial findings, selected
laboratory tests, treatment and outcome for all patients
in a standardized form. Thus, registration of pre-existing
medical conditions was based on patient history on
admission and available pre-existing data in the hospital
electronic patient registry. Patients with suspected influ-
enza were all coded with the ICD-10 code Z11.5 in our
electronic patient journal system. If pandemic H1N1
was confirmed, the patient received an additional ICD-
10 code (J09). This enabled us to track and record both
the suspected and confirmed cases. The inclusion of
new patients ended 30 November 2009, but patients
were followed until 15 December 2009.
Tests
All patients with suspected H1N1 Influenza A were
tested for virus using nasopharyngeal- and throat-swabs.
All specimens were analysed with RT-PCR. In brief, pur-
ification of viral RNA from respiratory specimens was
performed using the bioMérieux easyMAG Nuclisense
extractor (bioMerieux, Marcy-l’Etoile, France) according
to the manufacturer’si n s t r u c t i o n s .R T - P C Rw a sp e r -
formed with One-Step RT-PCR kit (Qiagen, Hilden,
Germany), using primers and probes to detect Influenza
A virus and 2009 pandemic H1N1 Influenza A virus
subtype as described elsewhere [10,11]. During the peak
of the pandemic outbreak in October 2009, samples
positive in the influenza A test were not tested for sub-
type, but all influenza A were considered to be pan-
demic H1N1. During the study period, specific tests for
pandemic H1N1 influenza A were performed on 54% of
all specimens analyzed for influenza in Norway, and
99.9% of the sub typed influenza viruses were confirmed
to be of pandemic H1N1 subtype.
Definition
We defined the suspicion of influenza as a patient with
fever and/or respiratory symptoms and/or generalized
symptoms of infection, such as myalgia, head-ache and
chills. We defined fever as a temperature > 38°C. We
used Kendall GENIUS 2 Infrared Tympanic Electronic
Thermometers and nurses who had received specific
training in operating the tympanic thermometers con-
ducted temperature measurements in this study.
Treatment
Oseltamivir was the preferred antiviral drug. Zanamivir
was available from October 2009, primarily used for
prophylaxis in pregnant women.
Hospital antibiotic guidelines recommend that com-
munity acquired pneumonias are treated with crystalline
penicillin in monotherapy. Normally a combination of
penicillin and gentamicin is used for septic patients,
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renal failure in H1N1 positive patients after gentamicin
treatment, septic H1N1 patients with hypotension or
oliguria were given cefotaxime in monotheraphy.
Ethics Statement
The hospital’s Data Protection Officer approved the
study protocol on behalf of the regional ethics commit-
tee. The research involved no risk to subjects nor
involved any procedures for which written consent is
required.
Statistical analysis
Statistical analyses were performed with SPSS 15.0 (Chi-
cago, Illinois, US). Categorical data were analysed using
the Fisher exact test. Data for continuous variables are
reported as median (range) and for categorical variables
as percentages. Logistic regression was used in the uni-
variate and multiple regression analyses. A p-value of
less than 0.05 was considered significant. The multivari-
a t ea n a l y s e sw e r ep e r f o r m e db ye n t e r i n gt h ev a r i a b l e s
t h a th a dap - v a l u eo f<0 . 1w i t hs u b s e q u e n tr e m o v a lo f
the least significant variables in a stepwise fashion.
Results
Patients with confirmed influenza A (H1N1)
From 15 July to 30 of November 2009 a total of 182
cases of suspected pandemic H1N1 were hospitalised, of
which 64 (35%) were confirmed pandemic H1N1 with
RT-PCR (Fig1). The Department of Gastroenterology
and Infectious Diseases had 498 admissions in this given
time-period in 2008 and 495 admissions in 2009.
The median age of patients with a positive influenza-
test was 42 years (19 - 69 years), and there were 26 men
(41%) and 38 women (59%). The median time from
onset of illness to hospital admission was three days
(range 0 - 20) and the median length of stay in hospital
was three days (0.3 - 47).
Fifty five (86%) of the 64 patients who tested positive,
had one or more underlying medical conditions. Patient
characteristics are shown in Additional file 1. Chronic
pulmonary disease was the most common predisposing
risk factor seen in 34% of the patients with Influenza A
(Additional file 1). Three patients (5%) were pregnant,
of whom one had a chronic pulmonary disease.
Demographics and vital signs at admission
The patients with positive H1N1 tests were significantly
younger, had a higher heart rate on admission, and were
more often non-ethnic Norwegians and healthcare
workers, compared to the H1N1 negative patients.
Established hypertension was more common in the
H1N1 negative group (Additional file 1).
Fever
Only 31 (48%) of the patients with confirmed pandemic
Influenza A had fever on admission (temperature mea-
surement available for 63 of 64 patients). Information
on the pre-admission use of antipyretic drugs (paraceta-
mol, ibuprofen and various immunosuppressants) was
scarcely available (N = 25 patients).
Bacteriology and antibiotics
Blood cultures were obtained in 51 patients (80%).
There was growth of Streptococcus pneumonia in two
cultures and of Streptococcus viridans in one, altogether
in 6%. All strains were susceptible to penicillin. Six
patients received antibiotics before admission. During
the hospital stay 33 patients (52%) received 47 treat-
ment-courses of antibiotics. Median duration of antibio-
tic treatment was six days The most common
antibiotics used were penicillin and cefotaxime. Eight
patiens received penicillin, where four of these changed
to cefotaxime. Similarly, six patients received cefotaxime
monotherapy, and 4 patients changed from cefotaxime
to penicillin.
Radiology
Chest radiography was performed in 59 (92%) of the
patients with influenza A and revealed pneumonia in 24
patients (41%). The comparative figures for H1N1 nega-
tive patients were 101 x-rays performed (86%) and 45
diagnosed with pneumonia (45%).
Antiviral treatment
One pregnant patient was offered treatment but
refused. Seven patients (11%) started oseltamivir before
admission to hospital, 44 (69%) started on the same
d a yt h e yw e r ea d m i t t e d ,t h er e m a i n i n ge i g h ts t a r t e d
oseltamivir one to four days after admission. No
patients received zanamivir. Four patients died - of
these one did not receive antiviral treatment, one
started oseltamivir two days prior to hospital admis-
sion and two patients started at admission. Six patients
needed mechanical ventilation - two of these had
started oseltamivir before admission, the remaining
four started at admission.
Vaccination
Six of the 64 patients with confirmed H1N1 Influenza A
had been vaccinated with 2009 H1N1-specific vaccines.
Two of these received their vaccine the same day as
they were admitted; the remaining four were vaccinated
one, two, 11 and 21 days prior to admission. One of the
six vaccinated patients died. This patient received the
vaccine 21 days prior to admission. He had an aggres-
sive chronic lymphatic leukaemia.
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Figure 1 shows the total number of admissions (both
patients with positive and negative tests) according to
week. There was a marked increase in the number of
admissions between week 41-47 and especially between
weeks 43-45. There was no recorded wave of 2009 pan-
d e m i cI n f l u e n z aAb e f o r et h i sb u tt h e r ew e r es o m e
sporadic cases.
T h el e n g t ho fs t a yf o rt h ep a t i e n t sw i t hap o s i t i v e
H1N1 test was relatively short (Figure 2) with a median
stay of 3 days.
ICU admissions and outcome
Of the patients with confirmed Influenza A, 27% were
admitted to the ICU compared to 15% of H1N1 negative
patients (ns). Clinical findings including fever, tachycar-
dia, tachypnea, and hypoxia was more prevalent in the
ICU admitted H1N1 positive patients compared to the
H1N1 positive patients admitted to the Infectious Dis-
ease (ID) ward consistent with the selection criteria for
ICU admission.
Putative associations between underlying medical con-
ditions and demographics were explored by univariate
analyses using admission to the ICU as the dependent
variable, and are described in Additional file 2. The
H1N1 positive patients admitted to the ICU tended to
be younger, have a higher heart rate, and had a higher
Body Mass Index (BMI) than the H1N1 negative ICU
admitted patients.
Hypertension was the only medical condition that was
significantly associated with a more serious outcome
defined by ICU admission or death, with a univariate
oddsratio of the composite endpoint in H1N1 positive
and negative patients of 6.1 (95% CI 1.3 - 29.3) and 3.2
(95% CI 1.2 - 8.7), respectively (Additional file 2).
Possible associations were further explored in a multi-
ple regression analysis with ICU admission as the
dependant variable. In the H1N1 negative patients,
hypertension did not remain significant in a stepwise
model, nor did any of the other variables (diabetes,
chronic heart failure and excessive alcohol consump-
tion). However, in the H1N1 positive patients,
0
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35
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Negative
Positive
Figure 1 Absolute number of positive and negative H1N1 tests according to week after the first positive test in week 29. There was a
marked increase from week 41 with a peak of patients in weeks 43 to 45.
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approximately 7 and p < 0,03 in all models.
Ten patients improved rapidly and left the ICU within
one (six patients) or two days (four patients). Most of
them were dehydrated and had moderate respiratory pro-
blems. One had Addisons disease and was admitted to the
ICU because of an Addison crisis. Among the seven
patients with three or more days in the ICU, two patients
had severe pneumococcal sepsis. Both survived after 26
and 14 days in the ICU and they both needed mechanical
ventilation. In total four patients (6%) died. All had at least
one risk factor (one patient had one risk factor, two had
two risk factors and one had three risk factors). One was
multi-handicapped and ventilator was not indicated of
ethical reasons. Another young patient with severe obesity
(BMI 37) had severe respiratory problems on admission
and died after six days of mechanical ventilation and four
days with extracorporeal membrane oxygenation (ECMO).
The patient’s mother, who had rheumatoid arthritis trea-
ted with hydroxychloroquine sulphate, was admitted to
our hospital after seven days with influenza symptoms.
After two weeks in the ICU she died of a viral pneumonia.
The last patient who died had an underlying aggressive
malignant haematological disease.
Secondary cases and absence from work
We had no secondary H1N1 Influenza A among the staff
and no increase in employers being absent from work at
the Departments of Infectious Diseases and Intensive
Care. One nurse on another ward who had been in con-
tact with one of the patients with influenza, tested positive
for H1N1 Influenza A, but recovered within seven days.
Patients with negative tests for Influenza A
The most common discharge-diagnoses for these patients
were pneumonia, septicaemia and other infections (e.g.
urinary tract, upper respiratory tract) (Figure 3). The
remaining patients had non-infection diagnoses like myo-
cardial infarction, trauma with fever and gastrointestinal
symptoms. Eight of the influenza negative patients (7%)
died. The characteristics of the patients with negative
tests for Influenza A are given in Additional file 1. Signs
and symptoms on admission could not help us determine
who would have a positive test for Influenza A.
Discussion
The most interesting findings in this study were: 1) pre-
existing hypertension was associated with more severe
morbidity and 2) the burden of patients with negative
influenza tests and the logistical aspect of admitting a
large number of possibly infected patients did not com-
promise care, nor did it create secondary infections in
our staff despite relatively simple hospital facilities. The
finding that two of the four patients who died were
related should lead to further investigation into possible
genetic factors associated with complicated outcomes.
Early in the course of the pandemic we realized that two
thirds of the patients with suspected influenza had nega-
tive influenza tests. The H1N1 positive patients were
younger, more often non-ethnic Norwegians, had a higher
heart rate on admission and less hypertension compared
to the H1N1 negative patients. However, the range of var-
iation was large and no single factor or set of factors could
reliably differentiate H1N1 positive from negative patients.
The number of patients that were admitted to an
intensive care unit is in accordance with reports from
other centres [12]. Four of seventeen (24%) patients in
the ICU died which is somewhat higher than in a report
from Australia and New Zealand [13].
Although there were more patients with established
hypertension among the H1N1 negative patients, hyperten-
sion was found to be a predictor of a more serious outcome
Figure 2 Frequency of length of stay.
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in the H1N1 positive patients remained hypertension a sig-
nificant predictor in a multivariate analysis. The prevalence
of hypertension in H1N1 positive patients with a more
severe morbidity has not been widely reported in recent
papers [14,15], however in an earlier report from Thailand
describing risk factors for a fatal outcome in influenza
patients (subtype A/H3N2, A/H1N1 and type B) they found
an increased prevalence of hypertension in fatal cases of
Influenza (age adjusted OR 4,7) supporting our findings [16].
We learned that clinical evaluation of the suspected
influenza patients in the Emergency Room could not
predict the result of an influenza test. But we could, to a
certain extent, predict that patients with one or more
co-morbidities would need intensive care treatment.
Few patients were seriously ill at the time of admission
despite a low proportion of patients having started anti-
viral treatment or antibiotics in the days before. Blood cul-
tures were obtained from 80% of the patients and were
positive in only 6%. All strains were susceptible to penicil-
lin. The most seriously ill patients that survived were two
young men with pneumococcal sepsis that needed ventila-
tory support. They had no underlying medical conditions
and in future planning for influenza pandemics pneumo-
coccal vaccination should be discussed.
The deceased patient with aggressive chronic lympha-
tic leukaemia received the vaccine 21 days prior to
admission, and it is doubtful whether the patient was
able to produce a sufficient immunological response to
the vaccine antigen.
The number of patients with pre-existing underlying
medical conditions was higher than in many other
reports. This may indicate that we tested too few
patients. The patients that died all died of respiratory
failure, but the number of deaths in this study is too
low for meaningful statistical analysis.
T h ea r e a sw i t hah i g hp e r c e n t a g eo fn o n - e t h n i cN o r -
wegians are also more densely populated, therefore our
finding of a higher percentage of non-ethnic Norwegians
with H1N1 positive tests could simply be due to a
higher infection rate in densely populated areas. The
finding that non-ethnic Norwegians tended to have a
lower than average admission rate to the ICU (ns) does
not support that a putative higher susceptibility to
H1N1 infection among non-ethnic Norwegians is asso-
ciated with a worse outcome. However, the numbers are
small and this aspect warrants further study.
We may have missed to diagnose influenza in some of
the patients: firstly, our criteria for testing may have
excluded some influenza-patients from being tested.
Secondly, some of the patients with signs of respiratory
tract disease were probably infected with pandemic
H1N1 despite negative tests. Nevertheless, 65% of the
patients who were tested had negative tests for Influenza
UTI = Urinary Tract Infection 
URI = Upper Respiratory tract Infection
Pneumonia (39%)
Septicaemia (13%)
UTI (7%)
URI (13%)
Infection, other (9%)
Tuberculosis (3%)
Other (17%)
Figure 3 Main diagnoses among the 118 patients with negative RT-PCR tests for Influenza A.
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virus present in the collected samples is below the
detection limit of the RT-PCR, either due to prolonged
time from onset of symptoms to sample collection, lim-
ited local viral replication in nasopharyngeal epithelial
cells or inadequate sample collection. The patients with
negative H1N1 tests counted for twice as many patients
as the patients with positive tests and contributed to a
great burden to the hospital because most of them had
to be isolated until their H1N1-status was known. In the
planning of future pandemics the health care system
must take into account the extra burden of all patients
with suspected and not only proven disease.
During the peak of patient admissions we were forced to
use some of the rooms without separate entrances. We
therefore had to change to protective clothing in the corri-
dor, which was not optimal. In addition we only used sur-
gical mouth masks and not health care respirator masks
(unless we performed vaporising procedures). In spite of
this, we had no secondary cases of Influenza A at our
ward or among our staff. This could be due to mass vacci-
nation early in the pandemic. In general, vaccination of
health care workers reduces the all-cause mortality of
older patients by approximately 40% [17]. We evaluated
on a daily basis if it was necessary to start using our
planned cohort isolation ward, something we never had to
do. The rapid daily services provided by the Department
of Microbiology enabled us to clear the ward and make
room for new patients at a high speed. During the peak of
admissions we managed to place all our patients in the
Department of Infectious Diseases and Intensive Care
Unit except at one occasion where we had to isolate two
patients in the Department of Cardiology.
Conclusions
Despite suboptimal facilities, such as lack of negative
air-pressure isolation rooms, we were capable of taking
care of the large burden of patients by increasing our
capacity from eight to 16 beds and by using the ICU.
We did not see any secondary cases among our staff.
The planned cohort-isolation unit was never in use.
Quick and reliable service from the virus-laboratory
with results of influenza testing the same day was neces-
sary for a high turnover of patients.
Planning for future pandemics should take into
account that some patients can acquire serious pneumo-
coccal infections and that many patients with suspected
H1N1 influenza have negative H1N1 tests. Hypertension
was the only pre-existing medical condition that was
associated with a more severe morbidity and outcome in
H1N1 positive patients. Thus, patients with hyperten-
sion should be considered candidates for H1N1 vaccina-
tion programs in future pandemics.
Additional material
Additional file 1: Table 1. Characteristics and outcome of all included
patients.
Additional file 2: Table 2. Comparison of patient characteristics with
respect to either ID Ward or ICU admission and odds-ratio for ICU
admission versus ID Ward admission given certain patient characteristics.
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